Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-06-14
Adverse events
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-04 (study day 83.0); relationship: PROBABLE
Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-09-04 (study day 83.0); relationship: PROBABLE
Mild APPLICATION SITE VESICLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-04 (study day 113.0); relationship: PROBABLE
Mild APPLICATION SITE VESICLES — outcome: RECOVERED/RESOLVED; onset 2013-10-04 (study day 113.0); relationship: PROBABLE
Mild ATRIAL HYPERTROPHY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-27 (study day 14.0); relationship: REMOTE
Mild ATRIAL HYPERTROPHY — outcome: RECOVERED/RESOLVED; onset 2013-06-27 (study day 14.0); relationship: REMOTE
Mild PAIN IN EXTREMITY — outcome: RECOVERED/RESOLVED; onset 2013-12-07 (study day 177.0); relationship: REMOTE
Data queries
No data queries.